BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12611422)

  • 1. Increased dietary potassium and magnesium attenuate experimental volume dependent hypertension possibly through endogenous sodium-potassium pump inhibitor.
    Pamnani MB; Bryant HJ; Clough DL; Schooley JF
    Clin Exp Hypertens; 2003 Feb; 25(2):103-15. PubMed ID: 12611422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanism of antihypertensive effect of dietary potassium in experimental volume expanded hypertension in rats.
    Pamnani MB; Chen X; Haddy FJ; Schooley JF; Mo Z
    Clin Exp Hypertens; 2000 Aug; 22(6):555-69. PubMed ID: 10972161
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of digitalis-like substance in the hypertension of streptozotocin-induced diabetes in reduced renal mass rats.
    Chen S; Yuan C; Clough D; Schooley J; Haddy FJ; Pamnani MB
    Am J Hypertens; 1993 May; 6(5 Pt 1):397-406. PubMed ID: 8390268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of digitalis-like substance in the hypertension of streptozotocin-induced diabetes and simulated weightlessness in rats.
    Pamnani MB; Chen S; Haddy FJ; Yuan C; Mo Z
    Clin Exp Hypertens; 1998; 20(5-6):509-21. PubMed ID: 9682907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of digitalis-like substance in experimental insulin-dependent diabetes mellitus hypertension.
    Chen S; Yuan C; Clough D; Haddy FJ; Pamnani MB
    J Cardiovasc Pharmacol; 1993; 22 Suppl 2():S20-1. PubMed ID: 7508018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of endogenous digoxin-like factor and digoxin antibody on myocardial Na+, K(+)-pump activity and ventricular arrhythmias in acute myocardial ischaemia in rats.
    Bagrov AY; Fedorova OV; Roukoyatkina NI; Zhabko EP
    Cardiovasc Res; 1993 Jun; 27(6):1045-50. PubMed ID: 8221762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antihypertensive effect of canrenone in a model where endogenous ouabain-like factors are present.
    de Mendonça M; Grichois ML; Pernollet MG; Wauquier I; Trouillet-Thormann B; Meyer P; Devynck MA; Garay R
    J Cardiovasc Pharmacol; 1988 Jan; 11(1):75-83. PubMed ID: 2450260
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium pump inhibition and regional expression of sodium pump alpha-isoforms in lens.
    Tao QF; Hollenberg NK; Graves SW
    Hypertension; 1999 Nov; 34(5):1168-74. PubMed ID: 10567200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium-potassium pump inhibitor in the mechanism of one-kidney, one wrap hypertension in dogs.
    Pamnani MB; Swindall BT; Schooley JF; Ghai R; Haddy FJ
    Cell Mol Biol (Noisy-le-grand); 1999 Feb; 45(1):115-21. PubMed ID: 10099845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological activity of partially purified digitalis-like substance and Na-K-ATPase inhibitor in rats.
    Morise T; Okamoto S; Takasaki H; Ikeda M; Takeda R; Kiuti F; Tuda Y
    Jpn Circ J; 1988 Nov; 52(11):1309-16. PubMed ID: 2852264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endogenous Na+ transport inhibitor in human hypertension: further biochemical and chemical studies.
    Cloix JF; Crabos M; Grichois ML; Guicheney P; Meyer P
    Klin Wochenschr; 1987; 65 Suppl 8():146-53. PubMed ID: 3037183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous ligand of alpha(1) sodium pump, marinobufagenin, is a novel mediator of sodium chloride--dependent hypertension.
    Fedorova OV; Talan MI; Agalakova NI; Lakatta EG; Bagrov AY
    Circulation; 2002 Mar; 105(9):1122-7. PubMed ID: 11877366
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of head down tilt on hemodynamics, fluid volumes, and plasma Na-K pump inhibitor in rats.
    Pamnani MB; Mo Z; Chen S; Bryant HJ; White RJ; Haddy FJ
    Aviat Space Environ Med; 1996 Oct; 67(10):928-34. PubMed ID: 9025814
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased myocardial Na+K+ATPase activity in rats with reduced renal mass-saline hypertension.
    Clough DL; Huot SJ; Pamnani MB; Haddy FJ
    J Hypertens; 1985 Dec; 3(6):583-9. PubMed ID: 3003189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endogenous digitalis-like substance and Na-K-ATPase inhibitor in cardiovascular and renal disease].
    Okamoto S
    Nihon Naibunpi Gakkai Zasshi; 1988 Jan; 64(1):39-50. PubMed ID: 2837414
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous digitalislike circulating substances in spontaneously hypertensive rats.
    Wauquier I; Pernollet MG; Grichois ML; Lacour B; Meyer P; Devynck MA
    Hypertension; 1988 Aug; 12(2):108-16. PubMed ID: 2457551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous immunoreactive ouabain-like and digoxin-like factors in reduced renal mass hypertensive rats.
    Takada T; Nakagawa M; Ura N; Kaide J; Yoshida H; Shimamoto K
    Hypertens Res; 1998 Sep; 21(3):193-9. PubMed ID: 9786604
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of ouabain-like factors and Na-K-ATPase inhibitors in hypertension--some old and recent findings.
    Haddy FJ; Pamnani MB
    Clin Exp Hypertens; 1998; 20(5-6):499-508. PubMed ID: 9682906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High sodium diet and circulating digitalis-like compound in the rat.
    Wauquier I; Pernollet MG; Delva P; Lacour B; Devynck MA
    J Hypertens; 1986 Aug; 4(4):463-9. PubMed ID: 2430012
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Digoxin-like immunoreactive factor in rat plasma: effect of sodium and calcium intake.
    Doris PA
    Life Sci; 1988; 42(7):783-90. PubMed ID: 2828804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.